Description

Product details

Laronib 100 Mg Product Details: Strength 100 mg Form Tablet Usage/Application Personal Compostion Larotrectinib 100 mg Prescription/Non prescription Non prescription Indication. VITRAKVI is indicated for the treatment of adult and pediatric patients with solid tumors that: have a neurotrophic receptor tyrosine kinase (NTRK) gene fusion without a known acquired resistance mutation, are metastatic or where surgical resection is likely to result in severe morbidity,

Keywords

• severe morbidity
• surgical resection
• solid tumors
• pediatric patients
• acquired resistance mutation
• prescription indication vitrakvi